Filter
Exclude
Time range
-
Near
$OCGN My Unbiased Take This is a pragmatic, standard biotech financing move from a position of clinical momentum rather than desperation. Ocugen had a decent cash position but high burn rate; repaying the Avenue loan while adding substantial new capital de-risks the balance sheet and buys time for the Phase 3 readouts without forcing an immediate reverse split or massive equity raise at depressed prices. It’s “smarter dilution” (potentially delayed and at higher prices) than selling stock outright today. That said, it’s still dilution risk down the road, and the market’s knee-jerk negative reaction is typical for these deals. The real value will show in whether the extra cash helps deliver clean pivotal data and partnerships. Haters can hate but I LOVE this move! Trust in our data and let science do the talking. Well play Mr. CEO @drsmusunuri #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
3
3
34
1,413
@drsmusunuri Hello Mr. CEO, I will have a YouTube video tomorrow from many silent voices that have been with you (Ocugen) since 2020. Many of whom are engineers, doctors, investors and believers in our data and company mission. I hope you watch it and digest it. There are options “BEFORE” any RS but we must play it right. The FUTURE is BRIGHT #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
4
33
912
5 years ago we were stonewalled out of the Covid vaccine market. If you were there for it, you’d know it was Fauci’s doing entirely. $OCGN Today we stand stronger than ever. On the verge of our first BLA, a nasal vaccine capable of being outfitted for anything and NeoCart. 😉🤙
2
8
59
2,178
$OCGN #OCUGEN #NeoCart 💥💥💥💥💥
7
34
1,246
$OCGN It's won't be long now, our CEO will break 1K followers. They are sleeping on my dawg! “MADE IN AMERICA” is the real deal ❤️🇺🇸🫡 #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
It is exciting to share 12-month results from the Phase 1 GARDian1 trial for #OCU410ST in individuals with early to advanced Stargardt disease, where no treatment currently exists. #Biotech
2
3
33
2,202
$OCGN We are climbing nicely BUT BUT BUT.. Here me out, take off “stop loss” trigger AND expect some bullshit manipulation in the coming weeks/months as we prepare for BLA(S) NFA, just sharing from experience sof the many bullshit I (we) had learn over the years. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
2
2
25
980
$OCGN Tell me you are shorting Ocugen without telling me OR 2nd guess is you have never review companies shares issues to their directors and employees? EITHER WAY I stick to what I know and keep throwing pencils every Friday. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
19 Dec 2025
Replying to @HieuTrantheMAN
“Not even management and the company’s leadership are showing confidence by buying shares of their own company? Why? Either there’s still a long road ahead, or the pipeline isn’t worth what you’re describing here…”
1
10
1,251
$OCGN “THEY” are trying so hard to keep Ocugen's stock down, so don’t feel bad when “THEY” burn and go bankrupt for trying to jeopardize a world-class, life-changing company. Question for my villagers, HAVE YOU been throwing pencils and adding more shares to your portfolio? For me, $100-$200 here and there will surely strengthen my family's legacy in due time. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
4
1
23
897
$OCGN Remember that January and February will be busy months for Ocugen but it’s also a busy month for “STOP LOSS” hunting so be careful with your precious shares. There will be days we open with -13% only to finish the day with 17% gains. Shorts play with fire so it’s fare to let them burn. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
1
4
26
896
$OCGN Did you buy during the sales? $1.09 was a solid purchase but you do you, I’ll throw my pencils on Friday and again next Friday and again next next Friday. The Future is BRIGHT! #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
2
6
341
Replying to @HieuTrantheMAN
have to sit back and accumulate
7
804
$OCGN I have tried to prepare everyone for days like today with videos explaining how our stock price will be after earnings reports. Those who watch understood what we are in for, those who don't are panicking. I will upload another 10 videos later today on our YouTube channel because I ain't going no where until we hit triple digit. Am I crazy? No, my vision is just superior. NFA, but enjoy the discount until the Japan news comes out “potentially” end of the year. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
3
2
27
979
$OCGN Years ago I asked Farmer to break this down for me privately and present day he's breaking it down for everyone to see. This is accurate and if you've been to Japan and talk to locals, Japan care for its people and they want top notch unmet medical technology to “HELP” prolong their people’s life . The FUTURE is BRIGHT. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
🧵 $ocgn Hot take: stocks push to $2.5 will be followed by a Japan partnership announcement and Astellas clearly looks like the partner. Why Astellas?
2
1
14
1,338
$OCGN Music to my ears and can't wait to see more “partnership” news in the near future. #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
#OCUGEN $OCGN..... Lots of interesting statements 🤔 Including "commercialization of OCU400 IN 2026" ...... meaning it will hit the marketplace in USA in 2026.
1
19
847
Encouraging to show that our gene therapy in clinical trials for dAMD and Stargardt has potential to target Autism - high unmet medical need @autismspeaks
2
11
557
$OCGN It seems today's ER call was new for some and it shows. For me, everything I needed to know was on track and my timeline I shared on our YouTube video is accurate. NFA, but I'll be throwing some pencils until our next catalyst which is also mentioned on our videos. The FUTURE is fooking BRIGHT! #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
5 Nov 2025
CEO @drsmusunuri shared our 3Q 2025 results today! We are advancing all our clinical programs and strengthening our cash position, remaining on track to file three BLAs in three years. 🔗bit.ly/4997lYt @FightBlindness @macular_org #Genetherapy #Biotech #Ocugen
1
3
26
1,405
$OCGN The more you read into Dr. @NeenaHaider creation the more you will fall in love with SCIENCE! We got the golden goose eggs and I can wait until they come to fruition. The FUTURE is BRIGHT! #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
3
16
1,025
$OCGN I strongly recommend my villagers read the peer review and digest it! “DE-RISKS” is 10000% accurate 🫡 #CourageousInnovation #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
$ocgn New peer reviewed paper on OCU400: Perfect safety Vector stays in the eye no anti NR2E3 issues NR2E3 expression holds This paper de risks our BLA and sweetens the math for partnership. Bullish sentiment tailwind inbound? I think so. 🍻
2
4
23
1,123
$OCGN The FUTURE is BRIGHT only if you research and trust the science instead of looking at the stock price every day. You do you, I will continue to research and share our leading science. #RetinitisPigmentosa #LeberCongenitalAmaurosis #GeneTherapy #CellTherapy #OCU500 #OCU200 #OCU400 #OCU410 #NeoCart
27 Oct 2025
Reported live from #AAO2025! We connected with @davidalmeidaMD to discuss Ocugen’s breakthrough modifier gene therapies, bringing hope to those affected by vision loss. Key takeaways: safety and efficacy. @aao_ophth #Ocugen #ClinicalResearch #BiotechInnovation
1
19
905